Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan.

Su FH, Chu FY, Bai CH, Lin YS, Hsueh YM, Sung FC, Yeh CC.

J Hepatol. 2013 Apr;58(4):684-9. doi: 10.1016/j.jhep.2012.11.036.

PMID:
23207141
2.

Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.

Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.

Vaccine. 2012 Jun 8;30(27):4034-9. doi: 10.1016/j.vaccine.2012.04.031.

PMID:
22531558
3.

Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.

Chang YC, Wang JH, Chen YS, Lin JS, Cheng CF, Chu CH.

BMC Public Health. 2014 Sep 23;14:991. doi: 10.1186/1471-2458-14-991.

4.

Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.

Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.

Egypt J Immunol. 2014;21(1):13-26.

PMID:
25204041
5.

Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.

Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295.

PMID:
21876562
6.

[Are teenagers immunized in infancy still protected against hepatitis B?].

Pokorska-Lis M, Marczyńska M.

Przegl Lek. 2010;67(1):13-7. Polish.

PMID:
20509565
7.

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.

Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN.

Vaccine. 2009 Mar 13;27(12):1858-62. doi: 10.1016/j.vaccine.2009.01.027.

PMID:
19186203
9.

Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.

Lu IC, Jean MC, Lin CW, Chen WH, Perng DS, Lin CW, Chuang HY.

Medicine (Baltimore). 2016 Sep;95(39):e5023. doi: 10.1097/MD.0000000000005023.

10.

Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.

Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.

Vaccine. 2011 Oct 13;29(44):7835-41. doi: 10.1016/j.vaccine.2011.07.098.

PMID:
21816197
11.

The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination.

Gu H, Yao J, Zhu W, Lv H, Cheng S, Ling L, Xia S, Chen Y.

Hum Vaccin Immunother. 2013 Jun;9(6):1292-5. doi: 10.4161/hv.24021.

12.

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

Duval B, Gîlca V, Boulianne N, De Wals P, Massé R, Trudeau G, De Serres G.

Pediatr Infect Dis J. 2005 Mar;24(3):213-8.

PMID:
15750456
13.

A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.

Giambi C, Bella A, Barale A, Montù D, Marchisio M, Oddone M, Zito S, Rapicetta M, Chionne P, Madonna E, Ciofi degli Atti ML.

BMC Infect Dis. 2008 Jul 28;8:100. doi: 10.1186/1471-2334-8-100.

14.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
15.

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children.

Yuen MF, Lim WL, Chan AO, Wong DK, Sum SS, Lai CL.

Clin Gastroenterol Hepatol. 2004 Oct;2(10):941-5.

PMID:
15476159
16.

The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.

Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.

Hum Vaccin. 2011 Oct;7(10):1055-9. doi: 10.4161/hv.7.10.15990.

PMID:
21989290
17.
18.

Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.

Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.

Clin Nephrol. 2007 Oct;68(4):228-34.

PMID:
17969490
19.

Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.

Williams JL, Christensen CJ, McMahon BJ, Bulkow LR, Cagle HH, Mayers JS, Zanis CL, Parkinson AJ, Margolis HS.

Vaccine. 2001 Jul 16;19(28-29):4081-5.

PMID:
11427285
20.

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.

Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A.

Infection. 2010 Aug;38(4):269-73. doi: 10.1007/s15010-010-0031-2.

Supplemental Content

Support Center